Literature DB >> 10540231

Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).

Y M Qian1, M Haino, K Kelly, W C Song.   

Abstract

CD97 is a newly identified, activation-associated human leucocyte antigen with seven putative transmembrane domains. It has an extended extracellular segment containing several adhesion molecule structure motifs, and has been shown to interact with the human complement regulator, decay-accelerating factor (DAF, CD55). To understand further the interaction between CD97 and DAF, as well as the structure and function of CD97 in general, we have cloned the mouse CD97 cDNA and studied the encoded protein for its membrane association property and ability to interact specifically with the murine decay-accelerating factor. The full-length mouse CD97 cDNA that we have cloned and characterized encodes a protein that is 60% identical to the three epidermal growth factor (EGF) domain-containing form of human CD97 but does not contain the Arg-Gly-Asp (RGD) motif which is present in human CD97. Two other alternatively spliced forms of mouse CD97 were also identified. These forms differ by the number of EGF-like sequence repeats present in the N-terminal region. Northern blot analysis revealed that CD97 is expressed widely in mouse tissues and in resting as well as activated cultured mouse splenocytes. Transient transfection of human embryonic kidney (HEK) 293 cells with the mouse CD97 cDNA in a green-fluorescence protein vector (pEGFP-N1) showed plasma membrane targeting of the expressed protein. Western blot analysis confirmed its membrane association and identified the existence of a processed C-terminal fragment, supporting the notion that CD97 on the cell membrane is composed of post-translationally generated subunits. Adhesion studies demonstrated that normal, but not DAF knockout mouse erythrocytes and splenocytes adhered to mouse CD97-transfected HEK cells. The interaction of CD97 and DAF was found to be species-restrictive in that human erythrocytes were unable to bind to mouse CD97-transfected HEK cells. These results indicate that the general structure, membrane association property and DAF-binding ability of CD97 are conserved and that the adhesive interaction between CD97 and DAF is independent of the RGD motif. The finding that CD97 is distributed widely among various mouse tissues suggests that CD97 may have other roles beyond lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540231      PMCID: PMC2326925          DOI: 10.1046/j.1365-2567.1999.00859.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Key residues involved in calcium-binding motifs in EGF-like domains.

Authors:  P A Handford; M Mayhew; M Baron; P R Winship; I D Campbell; G G Brownlee
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

Review 2.  The many faces of epidermal growth factor repeats.

Authors:  C G Davis
Journal:  New Biol       Date:  1990-05

3.  Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.

Authors:  X Sun; C D Funk; C Deng; A Sahu; J D Lambris; W C Song
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 4.  Decay-accelerating factor: biochemistry, molecular biology, and function.

Authors:  D M Lublin; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

5.  Characterization of an early activation-dependent antigen on lymphocytes defined by the monoclonal antibody BL-Ac(F2).

Authors:  W Eichler; G Aust; D Hamann
Journal:  Scand J Immunol       Date:  1994-01       Impact factor: 3.487

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  Coexistence of autologous antibodies and decay-accelerating factor, an inhibitor of complement, on human renal tumor cells.

Authors:  T Terachi; G Stanescu; J E Pontes; M E Medof; M J Caulfield
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

8.  How an epidermal growth factor (EGF)-like domain binds calcium. High resolution NMR structure of the calcium form of the NH2-terminal EGF-like domain in coagulation factor X.

Authors:  M Selander-Sunnerhagen; M Ullner; E Persson; O Teleman; J Stenflo; T Drakenberg
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

Review 9.  Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif.

Authors:  S E D'Souza; M H Ginsberg; E F Plow
Journal:  Trends Biochem Sci       Date:  1991-07       Impact factor: 13.807

10.  Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.

Authors:  K Koretz; S Brüderlein; C Henne; P Möller
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

View more
  22 in total

1.  Improved antibacterial host defense and altered peripheral granulocyte homeostasis in mice lacking the adhesion class G protein receptor CD97.

Authors:  Tao Wang; Linhua Tian; Makoto Haino; Ji-Liang Gao; Ross Lake; Yvona Ward; Hongshan Wang; Ulrich Siebenlist; Philip M Murphy; Kathleen Kelly
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

2.  Functional cross-interaction of the fragments produced by the cleavage of distinct adhesion G-protein-coupled receptors.

Authors:  John-Paul Silva; Vera Lelianova; Colin Hopkins; Kirill E Volynski; Yuri Ushkaryov
Journal:  J Biol Chem       Date:  2009-01-05       Impact factor: 5.157

Review 3.  Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury.

Authors:  Rachel L Zemans; Sean P Colgan; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

4.  Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.

Authors:  T Miwa; X Sun; R Ohta; N Okada; C L Harris; B P Morgan; W C Song
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

5.  Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity.

Authors:  Christopher B Toomey; David M Cauvi; Wen-Chao Song; Kenneth M Pollard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

Review 6.  International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.

Authors:  Anthony P Davenport; Stephen P H Alexander; Joanna L Sharman; Adam J Pawson; Helen E Benson; Amy E Monaghan; Wen Chiy Liew; Chidochangu P Mpamhanga; Tom I Bonner; Richard R Neubig; Jean Philippe Pin; Michael Spedding; Anthony J Harmar
Journal:  Pharmacol Rev       Date:  2013-05-17       Impact factor: 25.468

7.  Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells.

Authors:  Lihua Bao; Mark Haas; Jeffrey Pippin; Ying Wang; Takashi Miwa; Anthony Chang; Andrew W Minto; Miglena Petkova; Guilin Qiao; Wen-Chao Song; Charles E Alpers; Jian Zhang; Stuart J Shankland; Richard J Quigg
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

8.  Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice.

Authors:  Takashi Miwa; Michael A Maldonado; Lin Zhou; Xiujun Sun; Hong Yuan Luo; Dewei Cai; Victoria P Werth; Michael P Madaio; Robert A Eisenberg; Wen-Chao Song
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

9.  Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo.

Authors:  Hee Yeon Won; Se Hwan Mun; Bongjin Shin; Sun-Kyeong Lee
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

Review 10.  The EGF-TM7 family: a postgenomic view.

Authors:  Mark J Kwakkenbos; Else N Kop; Martin Stacey; Mourad Matmati; Siamon Gordon; Hsi-Hsien Lin; Jörg Hamann
Journal:  Immunogenetics       Date:  2003-11-27       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.